PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sorbitan, monooctadecanoate | 616-298-6 | 76169-00-1 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide | 278-388-8 | 76199-85-4 | - | - | 1 | - | - | - | - | - | - | Details |
| Diethyl phosphonate | 212-091-6 | 762-04-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Bisdecanoyl peroxide | 212-092-1 | 762-12-9 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Dioctanoyl peroxide | 212-094-2 | 762-16-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium 12-hydroxystearate | 231-536-5 | 7620-77-1 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-chloropropionyl chloride | 231-540-7 | 7623-09-8 | - | - | - | - | 1 | - | - | - | - | Details |
| [No public or meaningful name is available] | 482-010-9 | 762300-77-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 3-methylbut-3-en-1-ol | 212-110-8 | 763-32-6 | - | - | 1 | - | - | - | - | - | - | Details |
| Ethyl 3-ethoxypropionate | 212-112-9 | 763-69-9 | - | - | 2 | - | - | - | - | - | - | Details |
| Silicon dioxide | 231-545-4 | 7631-86-9 | 1 | - | 2 | - | 1 | 1 | - | - | - | Details |
| Sodium hydrogensulfite | 231-548-0 | 7631-90-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Disodium molybdate | 231-551-7 | 7631-95-0 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Sodium peroxometaborate | 231-556-4 | 7632-04-4 | - | - | - | - | - | 1 | 1 | 1 | - | Details |
| N,α-dimethylphenethylamine | 231-559-0 | 7632-10-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium tetrachloride | 231-561-1 | 7632-51-1 | - | - | - | - | 1 | - | - | - | - | Details |
| D-Glucitol, 1-deoxy-1-(dimethylamino)- | 810-394-3 | 76326-99-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Boron trifluoride | 231-569-5 | 7637-07-2 | - | - | 1 | - | - | - | - | - | - | Details |
| 1,1'-[oxybis(ethyleneoxy)]diethylene | 212-133-3 | 764-99-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Tin tetrachloride | 231-588-9 | 7646-78-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Cobalt dichloride | 231-589-4 | 7646-79-9 | - | - | 3 | - | 1 | - | 1 | 1 | - | Details |
| Zinc chloride | 231-592-0 | 7646-85-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Hydrogen chloride | 231-595-7 | 7647-01-0 | - | - | 1 | - | - | - | - | - | - | Details |
| Sodium chloride | 231-598-3 | 7647-14-5 | - | - | 3 | - | - | - | - | - | - | Details |
| Sodium bromide | 231-599-9 | 7647-15-6 | - | - | 3 | - | 1 | 1 | - | - | - | Details |